Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy

Journal of Epilepsy - Tập 9 - Trang 106-112 - 1996
M.K. Sharief1,2, P. Singh1,2, J.W.A.S. Sander1,2, P.N. Patsalos1,2, S.D. Shorvon1,2
1From the Epilepsy Research Group, Institute of Neurology, Queen Square, London, U.K
2From the National Hospital for Neurology and Neurosurgery and The Chalfont Centre for Epilepsy, Buckinghamshire, U.K.

Tài liệu tham khảo

Wülfert, 1989, Facilitation of calcium-dependent cholinergic function by ucb ucb L059, a new “sec-ond generation” nootropic agent, Psychopharmacol Bull, 25, 498 Gower, 1992, ucb L059, a novel anti-convulsant drug: pharmacological profile in animals, Eur J Pharmacol, 222, 193, 10.1016/0014-2999(92)90855-X Löscher, 1993, Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats, Eur J Pharmacol, 232, 147, 10.1016/0014-2999(93)90768-D Gower, 1933, Anticonvulsant effects of ucb L059 in rats: absence of tolerance or discontinuation after chronic administration, Epilepsia, 34, 50 The Commission on Classification, Terminology of the International League Against Epilepsy, 1981, Proposal for the re-vised clinical and electroencephalographic classification of epileptic seizures, Epilepsia, 22, 489, 10.1111/j.1528-1157.1981.tb06159.x The, 1989, Proposal for the re-vised classification of epilepsies and epileptic syndromes, Epilepsia, 30, 389, 10.1111/j.1528-1157.1989.tb05316.x Duncan, 1991, The Chalfont Seizure Severity Scale, J Neurol Neurosurg Psychiatry, 54, 873, 10.1136/jnnp.54.10.873 Chapman, 1984, Evaluation of an-ticonvulsant drugs in DBA/2 mice with sound-induced sei-zures, Arzneimittelforschung Drug Res, 34, 1261 Fisher, 1989, Animal models of the epilepsies, Brain Res Rev, 14, 245, 10.1016/0165-0173(89)90003-9 Swinyard, 1988, Mechanisms of anticon-vulsant drugs, Pharmacology, 2, 95 Verloes, 1988, Effects of nootropic drugs in a scopolamine-induced amnesia model in mice, Psychopharmacology, 95, 226, 10.1007/BF00174514 Chaudhry, 1992, Clinical use of piracetam in epileptic patients, Curr Ther Res Clin Exp, 52, 355, 10.1016/S0011-393X(05)80407-2 Brown, 1993, The effectiveness of piracetam in cortical myoclonus, J Movement Disorders, 8, 63, 10.1002/mds.870080112 Marescaux, 1984, A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetet-razol-induced seizures, Epilepsia, 25, 326, 10.1111/j.1528-1157.1984.tb04196.x